NASDAQ : BNGO
Bionano Genomics, Inc. — Financial statements
Healthcare · Medical Instruments & Supplies · United States
Last price 1.2 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 14.13M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Bionano Genomics, Inc. (BNGO) reported revenue of 30.18M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 30.18M | 28.51M | 30.78M | 36.12M | 27.80M | 17.98M |
| Revenue | 30.18M | 28.51M | 30.78M | 36.12M | 27.80M | 17.98M |
| Cost of Revenue | 15.84M | 15.32M | 30.40M | 26.55M | 21.86M | 14.11M |
| Gross Profit | 14.34M | 13.19M | 380.00K | 9.57M | 5.95M | 3.87M |
| Selling, General & Admin | 34.33M | 35.15M | 62.74M | 94.22M | 86.48M | 56.92M |
| Research & Development | 12.20M | 11.37M | 24.80M | 54.03M | 49.05M | 22.48M |
| Operating Expenses | 46.53M | 46.52M | 87.55M | 148.25M | 135.53M | 79.41M |
| Operating Income | -32.19M | -33.34M | -87.17M | -138.69M | -129.58M | -75.53M |
| Interest Expense | -282.00K | -298.00K | -2.04M | -5.12M | -298.00K | -927.00K |
| Interest & Investment Income | 914.00K | 1.11M | 2.10M | 3.31M | 1.51M | 236.00K |
| Other Non Operating Income (Expenses) | -537.00K | 6.20M | -4.69M | -15.38M | -123.00K | -59.00K |
| EBT Excluding Unusual Items | -32.10M | -26.33M | -91.79M | -155.87M | -128.50M | -76.28M |
| Merger & Restructuring Charges | -8.02M | -741.00K | -1.80M | -1.50M | ||
| Impairment of Goodwill | -77.28M | |||||
| Gain (Loss) on Sale of Investments | -100.00K | |||||
| Asset Writedown | -19.68M | |||||
| Other Unusual Items | 7.51M | 1.46M | -316.00K | -367.00K | ||
| Pretax Income | -32.10M | -26.33M | -111.98M | -232.43M | -130.71M | -78.15M |
| Income Tax Expense | 66.00K | 67.00K | 33.00K | 62.00K | 1.88M | -5.72M |
| Net Income | -32.16M | -26.39M | -112.02M | -232.49M | -132.60M | -72.44M |
| Net Income to Common | -32.16M | -26.39M | -112.02M | -232.49M | -132.60M | -72.44M |
| Shares Outstanding (Basic) | 9.54M | 5.45M | 1.27M | 569.00K | 482.02K | 461.30K |
| Shares Outstanding (Diluted) | 9.54M | 5.45M | 1.27M | 569.00K | 482.02K | 461.30K |
| EPS (Basic) | -3.37 | -4.85 | -88.13 | -408.60 | -275.09 | -157.02 |
| EPS (Diluted) | -3.37 | -4.85 | -88.13 | -408.60 | -275.09 | -157.02 |
| Free Cash Flow | -20.48M | -16.34M | -69.03M | -126.87M | -128.02M | -73.39M |
| Free Cash Flow Per Share | -2.15 | -3.00 | -54.31 | -222.97 | -265.58 | -159.09 |
| Gross Margin | 47.50% | 46.25% | 1.23% | 26.49% | 21.38% | 21.55% |
| Operating Margin | -106.68% | -116.95% | -283.23% | -384.00% | -466.09% | -420.08% |
| Profit Margin | -106.58% | -92.59% | -363.97% | -643.74% | -476.93% | -402.84% |
| Free Cash Flow Margin | -67.87% | -57.34% | -224.28% | -351.29% | -460.46% | -408.14% |
| EBITDA | -22.67M | -23.61M | -72.94M | -124.77M | -119.96M | -72.18M |
| EBITDA Margin | -75.12% | -82.81% | -237.01% | |||
| D&A For EBITDA | 9.52M | 9.73M | 14.23M | 13.91M | 9.62M | 3.35M |
| EBIT | -32.19M | -33.34M | -87.17M | -138.69M | -129.58M | -75.53M |
| EBIT Margin | -106.68% | -116.95% | -283.23% | |||
| Revenue as Reported | 30.18M | 28.51M | 30.78M | 36.12M | 27.80M | 17.98M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.73M | 2.99M | 9.17M | 17.95M | 5.09M | 24.57M |
| Short-Term Investments | 6.19M | 16.28M | 302.00K | 48.82M | 108.09M | 226.04M |
| Cash & Short-Term Investments | 9.92M | 19.27M | 9.47M | 66.77M | 113.19M | 250.61M |
| Accounts Receivable | 4.37M | 5.20M | 4.75M | 9.32M | 7.02M | 4.93M |
| Other Receivables | 12.00K | 22.00K | 342.00K | 474.00K | ||
| Receivables | 4.37M | 5.21M | 4.77M | 9.66M | 7.50M | 4.93M |
| Inventory | 5.20M | 5.45M | 11.12M | 22.89M | 29.76M | 12.39M |
| Prepaid Expenses | 4.89M | 618.00K | 703.00K | 1.10M | 1.39M | 4.48M |
| Other Current Assets | 14.84M | 13.42M | 39.69M | 5.47M | ||
| Total Current Assets | 24.88M | 45.39M | 39.49M | 140.12M | 157.30M | 272.41M |
| Property, Plant & Equipment | 18.95M | 21.16M | 24.32M | 32.48M | 28.96M | 20.93M |
| Goodwill | 77.29M | 56.16M | ||||
| Other Intangible Assets | 1.67M | 4.34M | 9.71M | 33.97M | 41.14M | 26.84M |
| Other Long-Term Assets | 2.10M | 2.69M | 3.15M | 7.83M | 2.81M | 749.00K |
| Total Assets | 47.59M | 73.58M | 76.67M | 214.40M | 307.50M | 377.10M |
| Accounts Payable | 4.56M | 5.59M | 6.96M | 10.38M | 12.53M | 10.77M |
| Accrued Expenses | 2.70M | 4.63M | 4.62M | 6.58M | 9.22M | 6.94M |
| Short-Term Debt | 9.98M | 20.36M | 69.80M | |||
| Current Portion of Leases | 876.00K | 946.00K | 3.25M | 2.44M | 2.54M | 1.77M |
| Current Income Taxes Payable | 162.00K | 272.00K | 729.00K | 1.10M | 825.00K | 677.00K |
| Current Unearned Revenue | 1.15M | 967.00K | 1.13M | 783.00K | 871.00K | 684.00K |
| Other Current Liabilities | 595.00K | 561.00K | 293.00K | 8.94M | 9.89M | 1.00M |
| Total Current Liabilities | 10.04M | 22.94M | 37.34M | 100.03M | 35.88M | 21.84M |
| Long-Term Leases | 5.83M | 5.97M | 3.68M | 7.17M | 9.12M | 8.93M |
| Long-Term Unearned Revenue | 118.00K | 249.00K | 267.00K | 154.00K | 127.00K | 146.00K |
| Other Long-Term Liabilities | 10.89M | 12.97M | 9.07M | |||
| Total Liabilities | 15.98M | 29.16M | 41.30M | 118.25M | 58.10M | 39.98M |
| Common Stock | 1.00K | 1.00K | 3.00K | 29.00K | ||
| Additional Paid-In Capital | 766.94M | 764.03M | 728.57M | 677.34M | 599.23M | 553.75M |
| Retained Earnings | -735.35M | -719.62M | -693.23M | -581.21M | -348.71M | -216.12M |
| Comprehensive Income & Other | 14.00K | 17.00K | 27.00K | 23.00K | -1.12M | -539.00K |
| Total Common Equity | 31.61M | 44.42M | 35.38M | 96.16M | 249.40M | 337.12M |
| Shareholders' Equity | 31.61M | 44.42M | 35.38M | 96.16M | 249.40M | 337.12M |
| Total Liabilities & Equity | 47.59M | 73.58M | 76.67M | 214.40M | 307.50M | 377.10M |
| Total Debt | 6.70M | 16.89M | 27.30M | 79.41M | 11.67M | 10.70M |
| Net Cash (Debt) | 3.21M | 2.38M | -17.82M | -12.64M | 101.52M | 239.92M |
| Net Cash Per Share | 0.34 | 0.44 | -14.02 | -22.22 | 210.61 | 520.08 |
| Filing Date Shares Outstanding | 11.78M | 11.09M | 3.01M | 911.57K | 510.40K | 482.69K |
| Total Common Shares Outstanding | 11.78M | 10.74M | 1.87M | 762.53K | 495.31K | 482.67K |
| Working Capital | 14.84M | 22.44M | 2.15M | 40.09M | 121.41M | 250.57M |
| Book Value Per Share | 2.68 | 4.14 | 18.96 | 126.10 | 503.52 | 698.44 |
| Tangible Book Value | 29.94M | 40.08M | 25.67M | 62.18M | 130.97M | 254.12M |
| Tangible Book Value Per Share | 2.54 | 3.73 | 13.76 | 81.55 | 264.41 | 526.48 |
| Machinery | 39.64M | 40.16M | 42.76M | 38.68M | 27.11M | 16.72M |
| Leasehold Improvements | 2.51M | 2.89M | 3.33M | 3.75M | 4.00M | 2.67M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -32.16M | -26.39M | -112.02M | -232.49M | -132.60M | -72.44M |
| Depreciation & Amortization | 9.52M | 9.73M | 14.23M | 13.91M | 9.84M | 3.37M |
| Loss (Gain) From Sale of Assets | 34.00K | 258.00K | 1.40M | |||
| Asset Writedown & Restructuring Costs | 19.68M | 77.28M | ||||
| Loss (Gain) From Sale of Investments | 14.00K | 23.00K | 66.00K | |||
| Stock-Based Compensation | 3.51M | 4.53M | 9.74M | 15.18M | 22.42M | 9.72M |
| Other Operating Activities | 651.00K | -4.99M | -6.12M | 15.69M | 3.40M | -4.93M |
| Change in Accounts Receivable | -871.00K | -448.00K | 4.14M | -2.30M | -2.25M | -493.00K |
| Change in Inventory | 3.05M | 4.92M | -587.00K | -4.15M | -23.68M | -15.93M |
| Change in Accounts Payable | -1.68M | -1.37M | -3.42M | -2.00M | 1.95M | 6.78M |
| Change in Other Net Operating Assets | -2.53M | -2.58M | 4.03M | -6.33M | -3.96M | 1.99M |
| Operating Cash Flow | -20.48M | -16.34M | -68.92M | -125.18M | -124.82M | -71.93M |
| Capital Expenditures | -103.00K | -1.69M | -3.20M | -1.46M | ||
| Sale of Property, Plant & Equipment | 26.00K | |||||
| Cash Acquisitions | 96.00K | -30.65M | -49.09M | |||
| Sale (Purchase) of Intangibles | -102.00K | |||||
| Investment in Securities | 18.48M | -12.75M | 73.94M | 25.75M | 116.69M | -226.91M |
| Other Investing Activities | -607.00K | |||||
| Investing Cash Flow | 18.48M | -12.75M | 73.84M | 24.16M | 82.77M | -278.06M |
| Short-Term Debt Issued | 18.00M | 80.00M | ||||
| Total Debt Issued | 18.00M | 80.00M | ||||
| Short-Term Debt Repaid | -4.88M | -5.00M | -9.00M | |||
| Long-Term Debt Repaid | -71.00K | -61.06M | -47.00K | -36.00K | -15.01M | |
| Total Debt Repaid | -12.22M | -4.95M | -66.06M | -9.05M | -36.00K | -15.01M |
| Net Debt Issued (Repaid) | -12.22M | -4.95M | -48.06M | 70.95M | -36.00K | -15.01M |
| Issuance of Common Stock | 16.02M | 31.11M | 44.45M | 57.83M | 23.62M | 352.82M |
| Other Financing Activities | -1.15M | -2.12M | -10.07M | -14.96M | -578.00K | -1.70M |
| Financing Cash Flow | 2.64M | 24.04M | -13.69M | 113.81M | 23.01M | 336.11M |
| Foreign Exchange Rate Adjustments | 28.00K | -11.00K | -7.00K | 65.00K | -38.00K | |
| Net Cash Flow | 669.00K | -5.06M | -8.78M | 12.86M | -19.08M | -13.88M |
| Free Cash Flow | -20.48M | -16.34M | -69.03M | -126.87M | -128.02M | -73.39M |
| Free Cash Flow Margin | -67.87% | -57.34% | -224.28% | -351.29% | -460.46% | -408.14% |
| Free Cash Flow Per Share | -2.15 | -3.00 | -54.31 | -222.97 | -265.58 | -159.09 |
| Levered Free Cash Flow | 2.35M | -4.58M | -2.62M | -97.26M | -61.27M | -38.49M |
| Unlevered Free Cash Flow | 2.52M | -4.39M | -1.35M | -94.06M | -61.08M | -37.91M |
| Cash Interest Paid | 1.35M | 1.67M | 10.65M | 1.65M | 298.00K | 1.91M |
| Change in Working Capital | -2.03M | 514.00K | 4.16M | -14.77M | -27.94M | -7.65M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 13.66M | 15.57M | 29.41M | 73.41M | 433.51M | 864.66M |
| Enterprise Value | 10.45M | 11.18M | 39.91M | 19.97M | 263.71M | 538.59M |
| Last Close Price | 1.15 | 1.53 | 17.30 | 113.40 | 876.00 | 1,794.00 |
| PS Ratio | 0.45 | 0.55 | 0.96 | 2.03 | 15.59 | 48.09 |
| PB Ratio | 0.43 | 0.35 | 0.83 | 0.76 | 1.74 | 2.56 |
| P/TBV Ratio | 0.45 | 0.39 | 1.15 | 1.18 | 3.31 | 3.40 |
| EV/Sales Ratio | 0.34 | 0.39 | 1.30 | 0.55 | 9.48 | 29.95 |
| Debt / Equity Ratio | 0.21 | 0.38 | 0.77 | 0.83 | 0.05 | 0.03 |
| Net Debt / Equity Ratio | -0.10 | -0.05 | 0.50 | 0.13 | -0.41 | -0.71 |
| Net Debt / EBITDA Ratio | 0.14 | 0.10 | -0.24 | -0.10 | 0.85 | 3.32 |
| Net Debt / FCF Ratio | 0.16 | 0.14 | -0.26 | -0.10 | 0.79 | 3.27 |
| Asset Turnover | 0.49 | 0.38 | 0.21 | 0.14 | 0.08 | 0.08 |
| Inventory Turnover | 2.29 | 1.85 | 1.79 | 1.01 | 1.04 | 1.80 |
| Quick Ratio | 1.42 | 1.07 | 0.38 | 0.76 | 3.36 | 11.70 |
| Current Ratio | 2.48 | 1.98 | 1.06 | 1.40 | 4.38 | 12.47 |
| Return on Equity (ROE) | -83.56% | -66.15% | -170.33% | -134.56% | -45.21% | -38.92% |
| Return on Assets (ROA) | -32.56% | -27.73% | -37.43% | -33.22% | -23.66% | -21.58% |
| Return on Capital Employed (ROCE) | -85.70% | -65.80% | -221.70% | -121.30% | -47.70% | -21.30% |
| Earnings Yield | -290.58% | -169.53% | -380.82% | -316.71% | -30.59% | -8.38% |
| FCF Yield | -150.56% | -104.98% | -234.66% | -172.83% | -29.53% | -8.49% |
| Buyback Yield / Dilution | -314.06% | -328.40% | -123.37% | -18.05% | -4.49% | -165.50% |